{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:20:50Z","timestamp":1767745250706,"version":"3.48.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,6]]},"DOI":"10.7759\/cureus.100951","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:17:21Z","timestamp":1767745041000},"source":"Crossref","is-referenced-by-count":0,"title":["Simultaneous Splenectomy and Partial Hepatectomy for Hepatocellular Carcinoma in a Cirrhotic Patient With Severe Hypersplenism: A Case Report"],"prefix":"10.7759","author":[{"given":"Tomoaki","family":"Daio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujo","family":"Kawashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shintaro","family":"Hirayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Tateishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junzo","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Haraguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouya","family":"Umeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seiko","family":"Harada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sosei","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoichi","family":"Hachitanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021, 71:209-49. 10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet JM","year":"2021","unstructured":"Llovet JM, Kelley RK, Villanueva A, et al.. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021, 7:6. 10.1038\/s41572-020-00240-3","journal-title":"Nat Rev Dis Primers"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1159\/000367749","article-title":"Selection criteria and current issues in liver transplantation for hepatocellular carcinoma","volume":"5","author":"Kaido T","year":"2016","unstructured":"Kaido T. Selection criteria and current issues in liver transplantation for hepatocellular carcinoma. Liver Cancer. 2016, 5:121-7. 10.1159\/000367749","journal-title":"Liver Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.13364","article-title":"Liver transplantation in Japan: Registry by the Japanese Liver Transplantation Society","volume":"49","author":"Umeshita K","year":"2019","unstructured":"Umeshita K, Eguchi S, Egawa H, et al.. Liver transplantation in Japan: Registry by the Japanese Liver Transplantation Society. Hepatol Res. 2019, 49:964-80. 10.1111\/hepr.13364","journal-title":"Hepatol Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases","volume":"68","author":"Marrero JA","year":"2018","unstructured":"Marrero JA, Kulik LM, Sirlin CB, et al.. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018, 68:723-50. 10.1002\/hep.29913","journal-title":"Hepatology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200104000-00004","article-title":"Hypersplenism","volume":"13","author":"Peck-Radosavljevic M","year":"2001","unstructured":"Peck-Radosavljevic M. Hypersplenism. Eur J Gastroenterol Hepatol. 2001, 13:317-23. 10.1097\/00042737-200104000-00004","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2008.03.009","article-title":"Thrombocytopenia associated with chronic liver disease","volume":"48","author":"Afdhal N","year":"2008","unstructured":"Afdhal N, McHutchison J, Brown R, et al.. Thrombocytopenia associated with chronic liver disease. J Hepatol. 2008, 48:1000-7. 10.1016\/j.jhep.2008.03.009","journal-title":"J Hepatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-021-00574-2","article-title":"Splenectomy improves liver fibrosis via tumor necrosis factor superfamily 14 (LIGHT) through the JNK\/TGF-\u03b21 signaling pathway","volume":"53","author":"Liang QS","year":"2021","unstructured":"Liang QS, Xie JG, Yu C, et al.. Splenectomy improves liver fibrosis via tumor necrosis factor superfamily 14 (LIGHT) through the JNK\/TGF-\u03b21 signaling pathway. Exp Mol Med. 2021, 53:393-406. 10.1038\/s12276-021-00574-2","journal-title":"Exp Mol Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v23.i18.3228","article-title":"Platelets in liver disease, cancer and regeneration","volume":"23","author":"Kurokawa T","year":"2017","unstructured":"Kurokawa T, Ohkohchi N. Platelets in liver disease, cancer and regeneration. World J Gastroenterol. 2017, 23:3228-39. 10.3748\/wjg.v23.i18.3228","journal-title":"World J Gastroenterol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61493-6","article-title":"Post-splenectomy and hyposplenic states","volume":"378","author":"Di Sabatino A","year":"2011","unstructured":"Di Sabatino A, Carsetti R, Corazza GR. Post-splenectomy and hyposplenic states. Lancet. 2011, 378:86-97. 10.1016\/S0140-6736(10)61493-6","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.4776","article-title":"Use of hepatectomy and splenectomy to treat hepatocellular carcinoma with cirrhotic hypersplenism","volume":"92","author":"Chen XP","year":"2005","unstructured":"Chen XP, Wu ZD, Huang ZY, Qiu FZ. Use of hepatectomy and splenectomy to treat hepatocellular carcinoma with cirrhotic hypersplenism. Br J Surg. 2005, 92:334-9. 10.1002\/bjs.4776","journal-title":"Br J Surg"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.21037\/atm-20-6748","article-title":"Does splenectomy significantly improve the prognosis of hepatocellular carcinoma patients with hypersplenism? A systematic review and meta-analysis","volume":"9","author":"Shi XB","year":"2021","unstructured":"Shi XB, Feng JK, Wang JH, Jiang XQ. Does splenectomy significantly improve the prognosis of hepatocellular carcinoma patients with hypersplenism? A systematic review and meta-analysis. Ann Transl Med. 2021, 9:641. 10.21037\/atm-20-6748","journal-title":"Ann Transl Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/hep.30561","article-title":"Lusutrombopag for the treatment of thrombocytopenia in patients with chronic liver disease undergoing invasive procedures (L-PLUS 2)","volume":"70","author":"Peck-Radosavljevic M","year":"2019","unstructured":"Peck-Radosavljevic M, Simon K, Iacobellis A, et al.. Lusutrombopag for the treatment of thrombocytopenia in patients with chronic liver disease undergoing invasive procedures (L-PLUS 2). Hepatology. 2019, 70:1336-48. 10.1002\/hep.30561","journal-title":"Hepatology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e3181bdf8ad","article-title":"Impact of antithrombin III concentrates on portal vein thrombosis after splenectomy in patients with liver cirrhosis and hypersplenism","volume":"251","author":"Kawanaka H","year":"2010","unstructured":"Kawanaka H, Akahoshi T, Kinjo N, et al.. Impact of antithrombin III concentrates on portal vein thrombosis after splenectomy in patients with liver cirrhosis and hypersplenism. Ann Surg. 2010, 251:76-83. 10.1097\/SLA.0b013e3181bdf8ad","journal-title":"Ann Surg"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1097\/00042737-200502000-00008","article-title":"Partial splenic embolization in patients with cirrhosis: efficacy, tolerance and long-term outcome in 32 patients","volume":"17","author":"N'Kontchou G","year":"2005","unstructured":"N'Kontchou G, Seror O, Bourcier V, et al.. Partial splenic embolization in patients with cirrhosis: efficacy, tolerance and long-term outcome in 32 patients. Eur J Gastroenterol Hepatol. 2005, 17:179-84. 10.1097\/00042737-200502000-00008","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e318211caf8","article-title":"Platelet administration via the portal vein promotes liver regeneration in rats after 70% hepatectomy","volume":"253","author":"Matsuo R","year":"2011","unstructured":"Matsuo R, Nakano Y, Ohkohchi N. Platelet administration via the portal vein promotes liver regeneration in rats after 70% hepatectomy. Ann Surg. 2011, 253:759-63. 10.1097\/SLA.0b013e318211caf8","journal-title":"Ann Surg"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.08.038","article-title":"Extrahepatic platelet-derived growth factor-\u03b2, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice","volume":"147","author":"Yoshida S","year":"2014","unstructured":"Yoshida S, Ikenaga N, Liu SB, et al.. Extrahepatic platelet-derived growth factor-\u03b2, delivered by platelets, promotes activation of hepatic stellate cells and biliary fibrosis in mice. Gastroenterology. 2014, 147:1378-92. 10.1053\/j.gastro.2014.08.038","journal-title":"Gastroenterology"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2019.7640","article-title":"Immunological consequences following splenectomy in patients with liver cirrhosis","volume":"18","author":"Hirakawa Y","year":"2019","unstructured":"Hirakawa Y, Ogata T, Sasada T, Yamashita T, Itoh K, Tanaka H, Okuda K. Immunological consequences following splenectomy in patients with liver cirrhosis. Exp Ther Med. 2019, 18:848-56. 10.3892\/etm.2019.7640","journal-title":"Exp Ther Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.141.7.663","article-title":"Prospective study of the incidence and risk factors of postsplenectomy thrombosis of the portal, mesenteric, and splenic veins","volume":"141","author":"Stamou KM","year":"2006","unstructured":"Stamou KM, Toutouzas KG, Kekis PB, et al.. Prospective study of the incidence and risk factors of postsplenectomy thrombosis of the portal, mesenteric, and splenic veins. Arch Surg. 2006, 141:663-9. 10.1001\/archsurg.141.7.663","journal-title":"Arch Surg"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S87580","article-title":"Simultaneous hepatectomy and splenectomy versus hepatectomy alone for hepatocellular carcinoma complicated by hypersplenism: a meta-analysis","volume":"8","author":"Li W","year":"2015","unstructured":"Li W, Shen SQ, Wu SM, Chen ZB, Hu C, Yan RC. Simultaneous hepatectomy and splenectomy versus hepatectomy alone for hepatocellular carcinoma complicated by hypersplenism: a meta-analysis. Onco Targets Ther. 2015, 8:2129-37. 10.2147\/OTT.S87580","journal-title":"Onco Targets Ther"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/437176-simultaneous-splenectomy-and-partial-hepatectomy-for-hepatocellular-carcinoma-in-a-cirrhotic-patient-with-severe-hypersplenism-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:17:21Z","timestamp":1767745041000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/437176-simultaneous-splenectomy-and-partial-hepatectomy-for-hepatocellular-carcinoma-in-a-cirrhotic-patient-with-severe-hypersplenism-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.100951","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,6]]}}}